All News #Library
Biotech
Nona Biosciences Co-Founds Immunological Disease Alliance
28 Jan 2026 //
PR NEWSWIRE
Nona Biosciences, Link Cell Therapies Enter CAR-T Collaboration
09 Jan 2026 //
PR NEWSWIRE
Nona Bio Expands Platform For Early Clinical Trial Acceleration
27 Dec 2025 //
INDPHARMAPOST
Nona Biosciences, Valink Therapeutics Ally To Hasten Biologics
17 Dec 2025 //
PR NEWSWIRE
Nona Biosciences, Pfizer Partner To Speed Up Antibody Discovery
19 Nov 2025 //
PR NEWSWIRE
Nona Bio Appoints Dr. Di Hong Ceo For Tech Innovation & Growth
14 Oct 2025 //
PR NEWSWIRE
Nona Biosciences, Visterra Partner on Next-Gen Biotherapeutics
12 Jun 2025 //
PR NEWSWIRE
Nona Biosciences and Pfizer to Present MesoC2 Study at 2025 ASCO
23 May 2025 //
PR NEWSWIRE
Nona Biosciences` Partner Pfizer Presents Data on TOP1i-Based ADC
27 Apr 2025 //
PR NEWSWIRE
Nona Bio, Atossa Partner for Advance Breast Cancer Therapies
10 Apr 2025 //
PR NEWSWIRE
Nona Bio Licenses B Cell Development Research from Uni of Alabama
19 Feb 2025 //
PR NEWSWIRE
Nona Bio Forms Collab with Invetx for Animal Health Biotherapeutics
03 Feb 2025 //
PR NEWSWIRE
Nona Bio Update on Collaborator DualityBio`s ADC with BeiGene
03 Jan 2025 //
PR NEWSWIRE
Nona Bio & Candid Therapeutics Collaborate on T-Cell Engagers
16 Dec 2024 //
PR NEWSWIRE
Nona Biosciences and Kodiak Partner on Antibody Therapies
09 Dec 2024 //
PR NEWSWIRE
Nona Biosciences Partners With Alkyon for Immunotherapeutics Discovery
24 Sep 2024 //
PR NEWSWIRE
Nona Biosciences And Umoja Partner On In Vivo CAR-T Therapies
12 Sep 2024 //
PR NEWSWIRE
AstraZeneca and Nona Biosciences sign agreement for monoclonal antibody
23 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Nona Bio, AstraZeneca Partner On Tumor Targeted Antibody Therapy
22 May 2024 //
PR NEWSWIRE
Nona Biosciences Enters into Collaboration Agreement with Boostimmune
26 Feb 2024 //
PR NEWSWIRE
Pfizer picks up early-stage ADC candidate cleared for solid tumor trials
15 Dec 2023 //
ENDPTS
Nona Biosciences Enters into a Global License Agreement with Pfizer for HBM9033
14 Dec 2023 //
PR NEWSWIRE
Harbour BioMed Reports Results of Phase Ib Clinical Trial of Porustobart
28 May 2023 //
PR NEWSWIRE
Nona Bio and Washington University join forces to tackle emerging RNA viruses
20 Apr 2023 //
PHARMABIZ

Market Place
Sourcing Support